More investment into research is all the more important given that we are close to formidable breakthroughs in many areas of respiratory diseases, such as molecular bacteriology and virology, development of vaccines and antiviral agents,
boosting host defence and
innate immunity, molecular pathology and personalised care for lung cancer.